Jul 20 2012
United Pharmacy Partners (UPPI) is pleased to announce the signing of a
5-year agreement with Novation, a leading health care supply chain
expertise and contracting company, to offer both low and high (PET)
radiopharmaceuticals. UPPI radiopharmacies have the ability to supply a
full scope of radiopharmaceutical products for both diagnostic and
therapeutic uses to assist members in servicing their patient's needs.
Novation provides sourcing services, as well as information and data
services to a broad range of healthcare providers in the United States.
In addition to providing both low and high radioisotopes to the member
sites served by Novation, UPPI will offer a host of support options to
those members. UPPI will offer quality programs in the areas of
Continuing Education and Reimbursement Support which can include hotline
support, webinars, facility audits, Healthcare Reform Consulting and
Accreditation assistance. BioDose Patient Management Systems, the
exceptional, easy to use patient management system which allows the
technologists to capture key patient data, manage patient studies,
electronically order/fax doses plus many more tasks is also available to
members.
Perry Polsinelli, President of UPPI, stated "We are excited about this
radiopharmaceutical contract award and the opportunity to provide
exceptional value, products, service and support to the members served
by Novation. UPPI is pleased to be able to help enhance the delivery of
quality nuclear pharmacy services to ensure effective and efficient
diagnostic outcomes for the patients these members serve.
The agreement commenced on July 1, 2012, and will be in place for a
period of five years.
AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness